187 related articles for article (PubMed ID: 22534528)
21. Malaria.
Persidis A
Nat Biotechnol; 2000 Jan; 18(1):111-2. PubMed ID: 10625409
[No Abstract] [Full Text] [Related]
22. Targeting Plasmodium liver stages: better late than never.
Borrmann S; Matuschewski K
Trends Mol Med; 2011 Sep; 17(9):527-36. PubMed ID: 21737347
[TBL] [Abstract][Full Text] [Related]
23. First-in-human evaluation of genetically attenuated Plasmodium falciparum sporozoites administered by bite of Anopheles mosquitoes to adult volunteers.
Spring M; Murphy J; Nielsen R; Dowler M; Bennett JW; Zarling S; Williams J; de la Vega P; Ware L; Komisar J; Polhemus M; Richie TL; Epstein J; Tamminga C; Chuang I; Richie N; O'Neil M; Heppner DG; Healer J; O'Neill M; Smithers H; Finney OC; Mikolajczak SA; Wang R; Cowman A; Ockenhouse C; Krzych U; Kappe SH
Vaccine; 2013 Oct; 31(43):4975-83. PubMed ID: 24029408
[TBL] [Abstract][Full Text] [Related]
24. Genetic engineering of attenuated malaria parasites for vaccination.
Khan SM; Janse CJ; Kappe SH; Mikolajczak SA
Curr Opin Biotechnol; 2012 Dec; 23(6):908-16. PubMed ID: 22560204
[TBL] [Abstract][Full Text] [Related]
25. Malaria vaccines: multiple targets.
Nussenzweig RS; Long CA
Science; 1994 Sep; 265(5177):1381-3. PubMed ID: 8073276
[No Abstract] [Full Text] [Related]
26. Designer Parasites: Genetically Engineered
Goswami D; Minkah NK; Kappe SHI
J Immunol; 2019 Jan; 202(1):20-28. PubMed ID: 30587570
[TBL] [Abstract][Full Text] [Related]
27. PATH Malaria Vaccine Initiative (MVI): perspectives on the status of malaria vaccine development.
Birkett AJ
Hum Vaccin; 2010 Jan; 6(1):139-45. PubMed ID: 20009524
[No Abstract] [Full Text] [Related]
28. Parasite Recognition and Signaling Mechanisms in Innate Immune Responses to Malaria.
Gowda DC; Wu X
Front Immunol; 2018; 9():3006. PubMed ID: 30619355
[TBL] [Abstract][Full Text] [Related]
29. The threat of artemisinin resistant malaria in Southeast Asia.
Hanboonkunupakarn B; White NJ
Travel Med Infect Dis; 2016; 14(6):548-550. PubMed ID: 27915001
[No Abstract] [Full Text] [Related]
30. Drug development: Holding out for reinforcements.
Eisenstein M
Nature; 2012 Apr; 484(7395):S16-8. PubMed ID: 22534526
[No Abstract] [Full Text] [Related]
31. Malaria--a shadow over Africa.
Miller LH; Greenwood B
Science; 2002 Oct; 298(5591):121-2. PubMed ID: 12364787
[TBL] [Abstract][Full Text] [Related]
32. Malaria vaccine: candidate antigens, mechanisms, constraints and prospects.
Carvalho LJ; Daniel-Ribeiro CT; Goto H
Scand J Immunol; 2002 Oct; 56(4):327-43. PubMed ID: 12234254
[TBL] [Abstract][Full Text] [Related]
33. Malaria as a reemerging disease.
Krogstad DJ
Epidemiol Rev; 1996; 18(1):77-89. PubMed ID: 8877332
[No Abstract] [Full Text] [Related]
34. Mosquito stage, transmission blocking vaccines for malaria.
Saul A
Curr Opin Infect Dis; 2007 Oct; 20(5):476-81. PubMed ID: 17762780
[TBL] [Abstract][Full Text] [Related]
35. A Temporizing Solution to "Artemisinin Resistance".
Wang J; Xu C; Liao FL; Jiang T; Krishna S; Tu Y
N Engl J Med; 2019 May; 380(22):2087-2089. PubMed ID: 31018065
[No Abstract] [Full Text] [Related]
36. Rational malaria chemoprophylaxis - The position of primaquine.
Baird JK
Travel Med Infect Dis; 2017; 17():3-4. PubMed ID: 28450186
[No Abstract] [Full Text] [Related]
37. Malaria.
Phillips MA; Burrows JN; Manyando C; van Huijsduijnen RH; Van Voorhis WC; Wells TNC
Nat Rev Dis Primers; 2017 Aug; 3():17050. PubMed ID: 28770814
[TBL] [Abstract][Full Text] [Related]
38. Controlled Human Malaria Infection: Applications, Advances, and Challenges.
Stanisic DI; McCarthy JS; Good MF
Infect Immun; 2018 Jan; 86(1):. PubMed ID: 28923897
[TBL] [Abstract][Full Text] [Related]
39. The role of anti-malarial drugs in eliminating malaria.
White NJ
Malar J; 2008 Dec; 7 Suppl 1(Suppl 1):S8. PubMed ID: 19091042
[TBL] [Abstract][Full Text] [Related]
40. Vaccination using radiation- or genetically attenuated live sporozoites.
Vaughan AM; Kappe SH
Methods Mol Biol; 2013; 923():549-66. PubMed ID: 22990804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
